Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
about
sameAs
Glutamate receptors in neuroinflammatory demyelinating diseaseImaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisFatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain StimulationNeuroendocrine immunoregulation in multiple sclerosisDual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte deathInhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.Glutamate, T cells and multiple sclerosis.Reduced creatine kinase B activity in multiple sclerosis normal appearing white matterIn vivo evidence of glutamate toxicity in multiple sclerosis.Habituation to pain in "medication overuse headache": a CO2 laser-evoked potential study.Venous endothelial injury in central nervous system diseasesIncreased expression of cystine/glutamate antiporter in multiple sclerosisT-cell metabolism in autoimmune disease.False positive radiographical evidence of pump catheter migration into the spinal cord.Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neuronsPotentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune EncephalomyelitisExcitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisMacrophages in inflammatory multiple sclerosis lesions have an intermediate activation statusOxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis?Autoantibodies and neurodegeneration in multiple sclerosis.Advancement of therapies for neuroprotection in multiple sclerosis.Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report.Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE modelsThe link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.Cannabinoids, multiple sclerosis and neuroprotection.White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosisDysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.The role of glutamate and its receptors in multiple sclerosis.Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.Metabolism of murine TH 17 cells: Impact on cell fate and functionSynaptopathy connects inflammation and neurodegeneration in multiple sclerosis.
P2860
Q21284455-F2360B08-E2B6-461A-9BD8-A644028F0C63Q26744629-4E35C42C-C7A2-4D68-BD64-1830D2B6B61FQ26773166-117FCFEB-7033-44F3-BB28-56E663B96744Q26864449-CA84C8FF-2787-4BEC-90EF-8FF42FC41F45Q28566860-94421E95-6242-4133-A269-E3B878E61B8EQ30530185-0338DAE2-B3F5-4DEA-A60C-FE2289516272Q31165986-0FCD6695-05EA-446E-897F-5A0DEABABFF3Q33593127-680A96CC-906A-4674-BB1E-4D99E59927FEQ34081836-4A3DA5B7-199B-42EC-9542-1B8FC6BCC215Q34237210-53CD05D4-547F-47CC-A669-E460C8419BC4Q35042424-2DA79C44-5159-4D79-AE88-8EA3A6CA48D9Q35052754-C125B606-3115-475D-934F-AD8E28CA9228Q35071556-180C74BF-8414-4F6E-B938-0C5A8B4DE2DFQ35146716-125776A5-7497-43EB-8BB9-4BBC0C0B9152Q35698250-970AD94D-5AC6-4453-8DF7-4C945ACDC79AQ35699016-1D5B5FFE-BC3A-4209-A463-E85A8986ABDCQ35731415-8E2C0324-A4D5-4C73-B134-9F1E64369273Q35853209-9FD643F2-4032-470B-B97E-848B2A76BD79Q36261303-517796B6-0F86-4B87-8341-928E2988B3E2Q36283207-3D6C5415-EEA3-4CFA-B439-3F0EEDD1B3DEQ36494558-1A83E068-CFA6-4F9C-8BCB-58C3D3DDDFA4Q36610373-09394D44-21EE-4A36-8AA6-3DD91EBCEEBAQ36722852-12A8517C-F2CE-4770-9174-8C86C3AAA53BQ36946331-A63BF3E4-6928-4845-A013-218D2B164459Q37180839-854E99F5-F812-4C14-9DEB-C619989980BCQ37256701-A4747F0E-919A-47A3-A970-22D9F5262E26Q37350716-098934EC-7344-4DC6-A031-6DF466A80E4FQ37403476-BE05DB7F-445D-4D79-818A-E105B11DF32AQ37586538-C88EEABB-04C3-496D-A3D4-F5699B083F77Q37601317-FAEAA955-35EB-4582-A7EF-020677349F41Q37635764-9FAFC89F-8C60-4300-99D6-DDDFD9BBDA44Q37800531-B541706B-7FC2-43E1-AF69-8236FD83D2D2Q37855933-FBE6099E-43B3-42C9-BBC4-1AD445C470F7Q37960199-3DF438C7-4999-40CD-B048-AB6ED68F0920Q37972980-5E92F87C-705F-4FC8-B9BA-4BD2117BA459Q38170257-B4FA3CB1-B79D-47E5-9588-6E8B6BFB36A7Q38196367-9D612786-9483-4B35-B134-2AD1B99E7EA0Q38196701-002BD700-4D47-4DC1-8436-B5CF72462BE0Q38439401-E1D879E6-87B0-405A-B2EB-B763F5D99FFEQ38639337-7C9E3111-E024-476A-9262-2D26A6DEAE3D
P2860
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@ast
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@en
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@nl
type
label
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@ast
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@en
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@nl
prefLabel
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@ast
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@en
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@nl
P2093
P3181
P1433
P1476
Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid
@en
P2093
Alessandro Floridi
Ardesio Floridi
Laura Greco
Paola Sarchielli
Virgilio Gallai
P304
P3181
P356
10.1001/ARCHNEUR.60.8.1082
P407
P577
2003-08-01T00:00:00Z